Bionano Genomics, Inc. - SIC # 8080 -

Ticker Exchange SIC # Website Latest Ticker
BNGO Nasdaq 8080 www.bionano.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bionano Genomics, Inc.

Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss - Jan 14th, 2025 1:00 pm
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results - Jan 13th, 2025 1:00 pm
Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia - Jan 7th, 2025 1:00 pm
BioNano Genomics Announces $10 Million Direct Offering - Jan 7th, 2025 12:30 pm
Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Jan 6th, 2025 9:30 pm
Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Jan 3rd, 2025 7:34 pm
Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway - Dec 31st, 2024 8:26 pm
Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis - Dec 23rd, 2024 1:30 pm
Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal - Dec 19th, 2024 1:00 pm
Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy - Dec 10th, 2024 1:00 pm
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Nov 14th, 2024 7:15 am
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript - Nov 14th, 2024 1:45 am
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress - Nov 13th, 2024 9:01 pm
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 - Nov 7th, 2024 9:01 pm
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Oct 31st, 2024 8:30 pm
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 - Oct 31st, 2024 12:10 pm
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - Oct 31st, 2024 12:00 pm
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma - Oct 24th, 2024 12:00 pm
Bionano Genomics Shares Fall After Lowered Q3 Revenue Guidance - Oct 10th, 2024 4:46 pm
Bionano Announces Preliminary 3Q 2024 Revenues and Cash - Oct 10th, 2024 12:00 pm